Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label study of mifepristone (VGX-410) for anti-HIV activity in HIV-1 infected patients
2005-000728-18Phase 2Completed
- Sponsor
- AISAR
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mifepristone in Human immunodeficiency virus infection type 1, sponsored by AISAR. Primary endpoints: Safety of mifepristone (VGX-410) and Anti-HIV activity of mifepristone (VGX-410). Started Mar 2007; status: completed.
02
Drugs
mifepristone
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2005-000728-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000728-18.